When it comes to gambling, many millions of people just don't know when to walk away. The behavior can take a tremendous toll on their finances and family life, and currently available treatments are often associated with extremely high relapse rates.
According to new research presented at the annual meeting of the American College of Neuropsychopharmacology (ACNP), however, there may be alternative and surprisingly simple treatments available for gambling addicts--medications that decrease urges and increase inhibitions. In other words, medications often used to treat drug abuse.
University of Minnesota scientists used tasks that measure cognition to identify what motivates the extreme gambling behavior. They enrolled men and women with a primary diagnosis of pathological gambling in one of three medication studies. Study sites varied in size from 70 to 100 participants.
The researchers sought to understand how gamblers decide whether or not to bet by focusing on two brain processes: urge and inhibition. In order to group individuals into categories that address differences in their biology, scientists separated pathological gamblers into two major subtypes: gamblers who are driven by urge (i.e., individuals who report gambling when the desire becomes too strong to control), and those who do not show normal inhibition of impulsive behaviors (i.e., individuals who report being unable to restrict behaviors even when urges are minimal or virtually non-existent).
In the first subtype, gamblers who are driven by urge responded well to treatment with medications that block the brain opioid system (e.g., naltrexone) or certain receptors for the neurotransmitter glutamate (e.g., memantine). The research team also found that family history plays an important role in refining this group even further. People with a family history of addiction responded even better to the opioid blocker, which has been shown in other studies to decrease the urge to use substances such as alcohol.
The second subtype, gamblers who have difficulty inhibiting their behaviors and react to the smallest desires, respond well to medications that act on a specific enzyme, catechol-O-methyl-transferase (COMT), which plays a major role in the function of the prefrontal cortex. Researchers found that decreasing the function of COMT can increase one's ability to inhibit their desire to gamble.
"By understanding these different subtypes, we are able to target the core biology of the illness with individualized treatment," said Jon Grant, MD, JD, MPH, Associate Professor of Psychiatry at the University of Minnesota and ACNP member.
"When we look at pathological gambling as an addiction and try to understand the sense of urges and inhibitions, we are able to target the treatment with medication more effectively."
Grant cautioned that while these results are exciting and a majority of people respond to these medications, there are still some for whom these medications do not work. Additional research is needed to further refine the subtypes.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Planet With Rings Found Outside Solar System - And They Are Bigger Than Saturn
- Age-related Macular Degeneration: Blindness Linked To Calcium Deposits In The Eye
- Think Mosquitoes Bite You More Than Other People? Here's Why You May Be Right
- Take Science Out Of The Climate Change Debate
- Gut Microbes Trigger Autoimmune Disease Later In Life In Mice
- Nutrition Labels Are Hard To Swallow
- Space-Time Warp Measured In J1906 - Then The Neutron Star Disappeared
- "With increasing amount of information collected the contemporary physics needs to move from specialized..."
- "Gender =/= Sex but even sex can be ambiguous. ..."
- "You liken people being unwilling to talk about mental illness to being raped? People don't take..."
- " ---Nearly Half Of Workers Won't Tell Their Boss About A Mental Health Problem And more than half..."
- "Hi Tommaso, where do you see the biggest advantage of this new review journal wrt. the various..."
- Breast cancer will soon be only the second most common deadly tumor for EU women
- Notch signaling: How cancer turns good cells to the dark side
- Flexible work schedules improve health and sleep for employees
- How to create a scientific process freed from systemic bias
- How to jump-start ecosystem restoration after oil-gas development
Books By Writers Here